These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 11501613)
1. Novel role for alpha1-adrenergic receptor subtypes in lower urinary tract symptoms. Schwinn DA BJU Int; 2000 Oct; 86 Suppl 2():11-20; discussion 20-2. PubMed ID: 11501613 [No Abstract] [Full Text] [Related]
2. The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms. Schwinn DA BJU Int; 2001 Sep; 88 Suppl 2():27-34; discussion 49-50. PubMed ID: 11589667 [No Abstract] [Full Text] [Related]
3. Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. Roehrborn CG; Schwinn DA J Urol; 2004 Mar; 171(3):1029-35. PubMed ID: 14767264 [TBL] [Abstract][Full Text] [Related]
4. alpha1-adrenergic receptors in the lower urinary tract and vascular bed: potential role for the alpha1d subtype in filling symptoms and effects of ageing on vascular expression. Schwinn DA; Michelotti GA BJU Int; 2000 Apr; 85 Suppl 2():6-11. PubMed ID: 10781179 [No Abstract] [Full Text] [Related]
5. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia. Andersson KE Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675 [TBL] [Abstract][Full Text] [Related]
6. Molecular pharmacology of human alpha1-adrenergic receptors: unique features of the alpha 1a-subtype. Schwinn DA; Price RR Eur Urol; 1999; 36 Suppl 1():7-10. PubMed ID: 10393466 [TBL] [Abstract][Full Text] [Related]
7. Mode of action of alpha1-adrenoreceptor antagonists in the treatment of lower urinary tract symptoms. Andersson KE BJU Int; 2000 Apr; 85 Suppl 2():12-8. PubMed ID: 10781180 [No Abstract] [Full Text] [Related]
9. Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats. Sugaya K; Nishijima S; Miyazato M; Ashitomi K; Hatano T; Ogawa Y Neurosci Lett; 2002 Aug; 328(1):74-6. PubMed ID: 12123863 [TBL] [Abstract][Full Text] [Related]
10. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? Barendrecht MM; Abrams P; Schumacher H; de la Rosette JJ; Michel MC Neurourol Urodyn; 2008; 27(3):226-30. PubMed ID: 17638312 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region. Hennenberg M; Tamalunas A; Wang Y; Keller P; Schott M; Strittmatter F; Herlemann A; Yu Q; Rutz B; Ciotkowska A; Stief CG; Gratzke C Eur J Pharmacol; 2017 May; 803():39-47. PubMed ID: 28315343 [TBL] [Abstract][Full Text] [Related]
12. alpha1-Adrenoceptor subtype selectivity and lower urinary tract symptoms. Schwinn DA; Price DT; Narayan P Mayo Clin Proc; 2004 Nov; 79(11):1423-34. PubMed ID: 15544022 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action for α Hattori T; Sugaya K Life Sci; 2017 Dec; 191():90-96. PubMed ID: 29032116 [TBL] [Abstract][Full Text] [Related]
14. [The role of alpha1-adrenoceptor subtypes in benign prostatic hyperplasia-from bed to bench]. Kojima Y; Hayase M; Imura M; Okada S; Kubota Y; Sasaki S; Hayashi Y; Kohri K Hinyokika Kiyo; 2008 Jun; 54(6):457-62. PubMed ID: 18634446 [TBL] [Abstract][Full Text] [Related]
15. Modulation of voiding and storage reflexes by activation of alpha1-adrenoceptors. de Groat WC; Yoshiyama M; Ramage AG; Yamamoto T; Somogyi GT Eur Urol; 1999; 36 Suppl 1():68-73. PubMed ID: 10393477 [TBL] [Abstract][Full Text] [Related]